| Gene | ERLIN2 |
| UniProt ID | O94905 |
| Mol. Weight | 37.8 kDa |
| Localization | Endoplasmic reticulum membrane |
| Family | Prohibitin domain family |
| Diseases | ALS, Hereditary Spastic Paraplegia |
Erlin2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ERLIN2 is an endoplasmic reticulum (ER) membrane protein encoded by the ERLIN2 gene. It forms a complex with ERLIN1 and plays essential roles in ER-associated degradation (ERAD), lipid metabolism, and cellular stress responses.
ERLIN2 contains several key structural domains:
- SPFH (stomatin/prohibitin/flotillin/HflK/C) domain: Core functional domain
- Transmembrane domains: Anchors the protein to the ER membrane
- Coiled-coil regions: Mediates oligomerization with ERLIN1
The protein forms ring-like complexes with ERLIN1, creating large oligomeric structures in the ER membrane.
ERLIN2 is a key component of ERAD:
- Substrate recognition: Identifying misfolded proteins in the ER
- Ubiquitination: Facilitating the ubiquitination of target proteins
- Retrotranslocation: Assisting in the extraction of proteins from the ER
- Proteasomal targeting: Directing substrates to the proteasome
A critical function of ERLIN2 is regulating IP3 receptors:
- Mediating degradation: Triggering degradation of activated IP3R
- Calcium homeostasis: Controlling calcium release from ER stores
- Signal termination: Turning off calcium signaling
ERLIN2 participates in lipid regulation:
- Cholesterol sensing: Responding to cellular cholesterol levels
- Lipid raft maintenance: Preserving ER membrane microdomains
- SREBP pathway: Modulating lipid biosynthesis
ERLIN2 mutations cause autosomal recessive HSP:
- Loss of ERAD function
- Accumulation of misfolded proteins
- ER stress activation
- Corticospinal tract degeneration
- Progressive lower limb spasticity
- Weakness
- Hyperreflexia
- Variable cognitive involvement
ERLIN2 contributes to ALS pathogenesis:
- ER stress: Exacerbating motor neuron stress
- Protein aggregation: Impaired clearance of TDP-43, SOD1
- Calcium dysregulation: Disrupted calcium homeostasis
- Selective vulnerability: Contributing to motor neuron death
Some mutations cause PLS:
- Upper motor neuron predominant
- Slower progression than ALS
- Preserved lower motor neurons
- ER stress reducers: Compounds that reduce ER stress
- ERAD enhancers: Boosting protein degradation capacity
- Calcium stabilizers: Normalizing calcium signaling
- Gene therapy: Delivering functional ERLIN2
- Chemical chaperones for ER stress
- Modulators of the ubiquitin-proteasome system
- Small molecules targeting ERLIN2 complexes
- Alazami AM, et al. "ERLIN2 mutations in HSP." Am J Hum Genet 2011.
- Pearce MM, et al. "ERLIN2 in ERAD." J Biol Chem 2009.
The study of Erlin2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Alazami AM, et al. ERLIN2 mutations. Am J Hum Genet 2011.
- Pearce MM, et al. ERLIN2 function. J Biol Chem 2009.